Search Results - "Lamina C"

Association of mitochondrial DNA copy number with metabolic syndrome and type 2 diabetes in 14 176 individuals.

Authors: Fazzini, F. Lamina, C. Raftopoulou, A. et al.

Source: Journal of Internal Medicine. Jul2021, Vol. 290 Issue 1, p190-202. 13p.

Visualizing interaction effects: a proposal for presentation and interpretation.

Authors: Lamina C Sturm G Kollerits B et al.

Source: Journal of Clinical Epidemiology. Aug2012, Vol. 65 Issue 8, p855-862. 8p.

The effect of the LPA variant P.THR3888PRO on lipoprotein(a) and coronary artery disease is modified by the LPA KIV-2 splice site variant 4925g>A.

Authors: Grüneis, R. Lamina, C. Di Maio, S. et al.

Source: Atherosclerosis (00219150). Aug2022, Vol. 355, pN.PAG-N.PAG. 1p.

Genome-wide association study on HDL-mediated cholesterol efflux capacity.

Authors: Schachtl-Riess, J.F. Lamina, C. Schönherr, S. et al.

Source: Atherosclerosis (00219150). Aug2022, Vol. 355, pN.PAG-N.PAG. 1p.

Lipoprotein(a) and SARS-CoV-2 infections: Risk for ischemic heart disease and thromboembolic events.

Authors: Di Maio, S. Lamina, C. Coassin, S. et al.

Source: Atherosclerosis (00219150). Aug2022, Vol. 355, pN.PAG-N.PAG. 1p.

Statin treatment and prevalent CVD influence the association between PCSK9 and incident CVD in patients with moderately decreased kidney function: Results from the GCKD study.

Authors: Kheirkhah, A. Lamina, C. Kollerits, B. et al.

Source: Atherosclerosis (00219150). Aug2022, Vol. 355, pN.PAG-N.PAG. 1p.

Strong association between serum PCSK9 and cardiovascular disease in patients with moderate chronic kidney diseases - The GCKD study.

Authors: Kheirkhah, A. Lamina, C. Kollerits, B. et al.

Source: Atherosclerosis (00219150). Aug2021, Vol. 331, pe48-e48. 1p.

Time-dependent lipid profile inversely associates with mortality in hemodialysis patients - independent of inflammation/malnutrition.

Authors: Ebert, T. Qureshi, A. R. Lamina, C. et al.

Source: Journal of Internal Medicine. Oct2021, Vol. 290 Issue 4, p910-921. 12p.

Mitochondrial DNA copy number is associated with all-cause mortality and cardiovascular events in patients with peripheral arterial disease.

Authors: Koller, A. Fazzini, F. Lamina, C. et al.

Source: Journal of Internal Medicine. May2020, Vol. 287 Issue 5, p569-579. 11p. 4 Charts, 2 Graphs.

23 GENETIC POLYMORPHISMS OF THE MAIN TRANSCRIPTION FACTORS FOR ADIPONECTIN GENE PROMOTER IN REGULATION OF PLASMA ADIPONECTIN LEVEL

Authors: Kedenko, L. Lamina, C. Kedenko, I. et al.

Source: Atherosclerosis (Supplements). Jun2011, Vol. 12 Issue 1, p5-5. 1p.

Association between apolipoprotein A- IV concentrations and chronic kidney disease in two large population-based cohorts: results from the KORA studies.

Authors: Stangl, S. Kollerits, B. Lamina, C. et al.

Source: Journal of Internal Medicine. Oct2015, Vol. 278 Issue 4, p410-423. 14p. 5 Charts, 1 Graph.

Meta-GWAS identifies FADS2 a novel locus for PCSK9 concentrations.

Authors: Kheirkhah, A. Schachtl-Rieß, J. Lamina, C. et al.

Source: Atherosclerosis (00219150). 2023 Supplement 1, Vol. 379, pS59-S59. 1p.

Genetic Geostatistical Framework for Spatial Analysis of Fine-Scale Genetic Heterogeneity in Modern Populations: Results from the KORA Study.

Authors: Diaz-Lacava, A. N. Walier, M. Holler, D. et al.

Source: International Journal of Genomics. 7/16/2015, Vol. 2015, p1-15. 15p. 4 Charts, 5 Graphs, 2 Maps.

Association of nicotinic acetylcholine receptor subunit α4 polymorphisms with nicotine dependence in 5500 Germans.

Authors: Breitling, L. P. Dahmen, N. Mittelstraß, K et al.

Source: Pharmacogenomics Journal. 2009, Vol. 9 Issue 4, p219-224. 6p. 4 Charts.

Apolipoprotein A-IV concentrations and clinical outcomes in haemodialysis patients with type 2 diabetes mellitus--a post hoc analysis of the 4D Study.

Authors: Kollerits B Krane V Drechsler C et al.

Source: Journal of Internal Medicine. Dec2012, Vol. 272 Issue 6, p592-600. 9p.

Genome-wide characterization of a highly penetrant form of hyperlipoprotein(a)emia causatively associated with genetically elevated cardiovascular risk.

Authors: Chemello, K. Coassin, S. Khantalin, I. et al.

Source: Atherosclerosis (00219150). Aug2021, Vol. 331, pe115-e115. 1p.

Highly frequent variants hidden in the KIV-2 region of LPA regulate lipoprotein(a) concentrations and lower coronary artery disease risk.

Authors: Schachtl-Riess, J.F. Kheirkhah, A. Grüneis, R. et al.

Source: Atherosclerosis (00219150). Aug2021, Vol. 331, pe6-e6. 1p.

A Comprehensive Map Of The Variability In The Lipoprotein(A) Kiv 2 Repeat Region And Follow-Up Of The Kiv-2 Arg20ter Mutation In 11,000 Individuals.

Authors: Coassin, S. Schönherr, S. Weissensteiner, H. et al.

Source: Atherosclerosis (00219150). Aug2019, Vol. 287, pe58-e58. 1p.

Plasma concentrations of afamin are associated with the prevalence and incidence of type 2 diabetes mellitus.

Authors: Kollerits, B. Huth, C. Kiechl, S. et al.

Source: Atherosclerosis (00219150). Sep2016, Vol. 252, pe217-e218. 1p.

Role of genetic polymorphisms at the adiponectin gene in regulation of adiponectin gene expression and circulating adiponectin levels.

Authors: Kedenko, L. Patsch, W. Kedenko, I. et al.

Source: Atherosclerosis (00219150). Sep2016, Vol. 252, pe81-e81. 1p.